Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) Enterprise Value (2019 - 2025)

IDEAYA Biosciences' Enterprise Value history spans 7 years, with the latest figure at -$639.4 million for Q4 2025.

  • For Q4 2025, Enterprise Value rose 5.46% year-over-year to -$639.4 million; the TTM value through Dec 2025 reached -$639.4 million, up 5.46%, while the annual FY2025 figure was -$639.4 million, 5.46% up from the prior year.
  • Enterprise Value for Q4 2025 was -$639.4 million at IDEAYA Biosciences, down from -$298.9 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$102.8 million in Q2 2023 and bottomed at -$701.7 million in Q2 2024.
  • The 5-year median for Enterprise Value is -$300.6 million (2021), against an average of -$343.3 million.
  • The largest annual shift saw Enterprise Value tumbled 582.26% in 2024 before it surged 83.66% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$246.8 million in 2021, then plummeted by 47.84% to -$364.8 million in 2022, then tumbled by 43.93% to -$525.1 million in 2023, then fell by 28.79% to -$676.3 million in 2024, then grew by 5.46% to -$639.4 million in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Enterprise Value are -$639.4 million (Q4 2025), -$298.9 million (Q3 2025), and -$114.6 million (Q2 2025).